This inventor holds 2 USPTO granted patents and 2 EPO patents. Top assignees: Lek Pharmaceuticals D.d., Lek, Tovarna Farmacevtskih in Kemicnih Izdelkov, D.d., Ljubljana. Active years: 1996-2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1996-2011
Title: Zdenka Jerala-Strukelj: Innovator in Pharmaceutical Formulations
Introduction
Zdenka Jerala-Strukelj is a notable inventor based in Mavcice, Slovenia. She has made significant contributions to the field of pharmaceuticals, particularly in the formulation of stable pharmaceutical compositions. With a total of 2 patents, her work has had a meaningful impact on drug development.
Latest Patents
One of her latest patents is focused on a stable pharmaceutical composition that includes sirolimus. This invention relates to a formulation that contains sirolimus in an amorphous form, combined with a fatty acid ester, such as glyceryl behenate, and a pharmaceutically acceptable polymer. The fatty acid ester is present at a concentration of less than 10% w/w compared to the total weight of the composition. Another significant patent involves novel inclusion complexes of racemic 1,4-dihydropyridines and their enantiomers, which are designed to enhance the efficacy of these compounds.
Career Highlights
Throughout her career, Zdenka has worked with several prominent companies in the pharmaceutical industry. She has been associated with Lek, Tovarna Farmacevtskih in Kemicnih Izdelkov, D.d., Ljubljana, and Lek Pharmaceuticals D.d. Her experience in these organizations has contributed to her expertise in pharmaceutical formulations.
Collaborations
Zdenka has collaborated with notable colleagues, including Darja Fercej-Temeljotov and Janko Zmitek. These collaborations have further enriched her research and development efforts in the pharmaceutical sector.
Conclusion
Zdenka Jerala-Strukelj is a distinguished inventor whose work in pharmaceutical formulations has led to valuable innovations. Her contributions continue to influence the field and enhance the development of effective drug therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile